InvestorsHub Logo
Followers 0
Posts 3727
Boards Moderated 0
Alias Born 10/23/2017

Re: BioInfo post# 201332

Thursday, 11/29/2018 3:48:46 PM

Thursday, November 29, 2018 3:48:46 PM

Post# of 699605
I disagree. NWBO does not have the infrastructure or experience to take this anywhere without help, and not just monetary help. If LP truly wants help patients, she HAS to do a deal. I think it would have been done already except for the delay in the trial completion. I believe her end game is to get clear indication of trial success data and then cash out, hand it over to BP to bring to market. That would be my preference, but the other alternative IMO is licensing deals.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News